Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/25/2007WO2006031313A3 Methods and compositions for cell activation
10/25/2007WO2006007448A3 Pharmaceutical co-crystal compositions and related methods of use
10/25/2007WO2005081897A3 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber
10/25/2007WO2004094595A3 MODIFIED iRNA AGENTS
10/25/2007WO2003011210A3 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007WO2002048116A3 Inhibitors of hepatitis c virus ns3 protease
10/25/2007WO2002017853A3 Hyaluronan-based antiadhesion compositions, their preparation and use
10/25/2007US20070249833 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
10/25/2007US20070249831 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
10/25/2007US20070249830 Reference standard for characterization of rosuvastatin
10/25/2007US20070249822 Photolabile Coumarinylmethyl Esters of Cyclic Nucleotides, Methods for their Preparation and Their Use
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249732 Use of certain phenyl napthyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms)
10/25/2007US20070249731 Abnormal cannabidiols as agents for lowering intraocular pressure
10/25/2007US20070249730 Intravenous Propofol emulsion compositions having preservative efficacy
10/25/2007US20070249729 Method of Treating Elevated Plasma Homocysteine Levels in Esrd Patients
10/25/2007US20070249728 Synergistic Anti-Inflammatory Pharmaceutical Compositions and Methods of Use
10/25/2007US20070249727 Compositions and kits useful for treatment of respiratory illness
10/25/2007US20070249726 treating wasting in a hypogonadal male with chronic obstructive pulmonary disorder, especially a loss of muscle mass; reducing side effects while elevating serum testosterone levels
10/25/2007US20070249725 Pharmaceutical formulations of sympathetic antagonist for the treatment of chronic muscle pain
10/25/2007US20070249724 Method of inhibiting inflammatory pain
10/25/2007US20070249723 Methods for preparing sulfonamide compounds
10/25/2007US20070249722 Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors
10/25/2007US20070249721 Hair Restorer
10/25/2007US20070249720 Thiourea Derivative-Containing Pharmaceutical Composition Having Improved Solubility and Bioavailability
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249718 Stable gabapentin compositions
10/25/2007US20070249717 Preventive/therapeutic agent for visceral pain
10/25/2007US20070249716 Illuminator for photodynamic therapy
10/25/2007US20070249715 treating schizophrenia in a patient by administering an effective amount of 4,4-dimethylcyclohexylamine
10/25/2007US20070249714 Method of treating skin requiring fractional resurfacing treatment
10/25/2007US20070249713 Prevention of Retinopathy by Inhibition of the Visual Cycle
10/25/2007US20070249711 Triterpene Compounds which are Effective on Improvement of Brain Function
10/25/2007US20070249710 Biaromatic compounds and cosmetic/pharmaceutical applications thereof
10/25/2007US20070249709 Crystal forms of (S)-(8(2,6-dichlorophenyl)-6-fluoro-2,3-dihydro benzo[b][1,4]dioxin-2-yl)methanamine hydrochloride salt
10/25/2007US20070249708 C7 ester and c10 hydroxy substituted taxanes
10/25/2007US20070249707 Taxanes having c7 hydroxy and c10 heterosubstituted acetate substituents
10/25/2007US20070249706 Use of certain biphenyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms)
10/25/2007US20070249705 N-(1-(2,3-Dihydro-1H-Inden-5Yl)-2-Oxo-3-Pyrrolidinyl)-Sulfonamide Derivatives for Use as Factor Xa Inhibitors
10/25/2007US20070249704 Process for the preparation of fluvastatin sodium salt
10/25/2007US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents
10/25/2007US20070249702 Calcilytic compounds
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249700 Pyrazolone Compounds Useful for Treatment of Cerebrovascular Disorders Associated with Ischemic Stroke
10/25/2007US20070249698 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
10/25/2007US20070249697 3-[3-(3-chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]propane-1-sulfonic acid amide; anti-androgen activity; treatment of prostate cancer, benign prostatic hypertrophy, male pattern baldness, sexual precociousness, common acne, seborrhea
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249695 Preventive and/or Therapeutic Agents for Meniere's Disease
10/25/2007US20070249694 Metaxalone formulations and methods for the preparation thereof
10/25/2007US20070249693 Total synthesis of salinosporamide a and analogs thereof
10/25/2007US20070249692 Inhibitors of crystallization in a solid dispersion
10/25/2007US20070249691 Mercaptoimidazoles as Ccr2 Receptor Antagonists
10/25/2007US20070249690 N-[2-(4-Pyridinyl)Ethyl]Benzamide Derivatives as Fungicides
10/25/2007US20070249689 Pre-mixed, ready-to-use pharmaceutical compositions
10/25/2007US20070249688 3-{4-[1-(4'-tert-butyl-2,6-dimethyl-biphenyl-4-yloxy)-4,4,4-trifluoro-butyl]-benzoylamino}-propionic acid; treat diabetic and other glucagon related metabolic disorders
10/25/2007US20070249687 Antivirals; anti-HIV drugs with other mechanism of action to prevent cross-resistance
10/25/2007US20070249686 Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
10/25/2007US20070249685 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent
10/25/2007US20070249684 Solid Forms of the Magnesium Salt of S-Omeprazole and Processes for Their Preparation
10/25/2007US20070249683 Dicarboxamide derivatives
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070249681 Blocking both sensory and motor nerves by using an anesthetic comprising a mixture of levobupivacaine and dextrobupivacaine or salts in the ratio of 75:2; cardiotoxic profile similar to that of enantiomeric pure levobupivacaine; optics; efficiency
10/25/2007US20070249680 Inhibitors of c-fms kinase
10/25/2007US20070249679 inhibitor of serotonin reuptake transporter protein; as tachykinin antagonists treating nervous system disorders, psychological disorders, rheumatoid arthritis; 1-[(3,5-dichlorophenyl)methyl]-3-[4-(4-fluorophenyl)-1-methyl-4-piperidinyl]-1,3-dihydro-2H-imidazol-2-one; cyclization preparation
10/25/2007US20070249678 Synthesis and uses of pyroglutamic acid derivatives
10/25/2007US20070249677 Treatment of Osteoarthritis and Dosing Regimen for Arzoxifene
10/25/2007US20070249676 Cyanoguanidine prodrugs
10/25/2007US20070249675 Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
10/25/2007US20070249674 Crystalline forms of a dimethylphenyl compound
10/25/2007US20070249673 Method for administering tolperisone
10/25/2007US20070249672 IL-8 Receptor Antagonists
10/25/2007US20070249671 Pharmaceutical composition for piperidinoalkanol compounds
10/25/2007US20070249670 Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof
10/25/2007US20070249668 Control of atp release by red blood cells and therapeutic applications thereof
10/25/2007US20070249667 Use of Substituted Quinoline Derivatives for the Treatment of Drug Resistant Mycobacterial Diseases
10/25/2007US20070249666 P2X7 Antagonists to Treat Affective Disorders
10/25/2007US20070249665 1-aryl-4-substituted isoquinolines
10/25/2007US20070249664 Muscle relaxants; respiratory system disorders; asthma;COPD; emphysema; bronchitis
10/25/2007US20070249663 Corticotropin-Releasing Factor (CRF) receptor antagonist as therapeutic agent for depression, depressive symptom, or irritable bowel syndrome
10/25/2007US20070249662 5-methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl}-1H-benzimidazole; chemical intermediates for safer oxidation of the thioether intermediate to give the sulfinyl derivative, omeprazole; ("prazoles", antisecretory agents); by-product inhibition
10/25/2007US20070249661 Compounds for inflammation and immune-related uses
10/25/2007US20070249660 Pharmacologically Acceptable Salts of Clopidogrel
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249658 Pyrrolo[3,2-C]Pyridine Deriatives and Processes for the Preparation Thereof
10/25/2007US20070249657 1-Aza-Bicyclo3.3.1Nonanes
10/25/2007US20070249656 administering by inhalation or nasal route a suspension of crystalline tiotropium bromide monohydrate in propellant gases HFA 227 and/or HFA 134a, optionally in admixture with other propellant gases chosen from propane, butane, pentane, dimethylether, CHClF2, CH2F2, CF3CH3, isobutane etc.; asthma; COPD
10/25/2007US20070249655 4-Substituted-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones
10/25/2007US20070249654 Solution polymerization of 1,3-dioxolane-2,4-diones in the presence of a basic N-heterocycle such as a 2- or 4-(dialkylamino)pyridine or a 1-alkylimidazole; number or weight average molar weight of the obtained polymer is a quasi-linear function of the initial monomer/(catalytic system) molar ratio
10/25/2007US20070249653 Tetracyclic benzamide derivatives and methods of use thereof
10/25/2007US20070249652 Phenanthridinium Derivatives as Dna Binding Agents
10/25/2007US20070249651 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
10/25/2007US20070249650 isolating and purifying quaternary ammonium alkaloid species from medicinal plant of Yan Huang Lian (Corydalis saxicola Bounting) through solvent extraction, crystallization and recrystallization; for treating viral hepatitis, hepatic injury, influenza, AIDS, tumors or arrhythmia
10/25/2007US20070249649 Inhibitors of c-fms kinase
10/25/2007US20070249648 Novel Diazaspiroalkanes and Their Use for Treatment of Ccr8 Mediated Diseases
10/25/2007US20070249647 Substituted CIS- and trans-stilbenes as therapeutic agents
10/25/2007US20070249646 Use of tetrahydropyridines in the treatment of central nervous system disorders
10/25/2007US20070249645 Such as N-(3-Benzyloxy-phenyl)-N-(4-thiazol-2-yl-pyrimidin-2-yl)-amine; allergic diseases, cancer, neurodegenerative and proliferative disorders, diabetes; inhibitors of GSK-3, Aurora2, and Syk protein kinases
10/25/2007US20070249644 Compounds and methods for the treatment of asthma
10/25/2007US20070249643 Solid pharmaceutical dosage form
1 ... 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 ... 7860